Table 3.
Serum changes in kidney and liver function parameters in diabetic rats and after camel milk administration for 2 months.
| Group | Urea(mg/dL) | Creatinine(mg/dL) | GPT (U/L) | GOT (U/L) |
|---|---|---|---|---|
| Control (C) | 43.0±9.2 | 0.8±0.1 | 103.6±7.7 | 90.6±7.6 |
| Diabetes (D) | 111.7±14.8* | 2.4±0.2* | 169.1±15.1* | 181.1±5.1* |
| Diabetes + metformin (D+ME) | 69.0±22.4# | 1.1±0.3# | 99.2±25.3# | 121.7±14.9# |
| Control + Camel milk (C+CM) | 40.7±5.8 | 0.9±0.2 | 86.0±2.5 | 96.0±16.3 |
| Diabetes + Camel milk (D+CM) | 66.2±8.5# | 0.7±0.02# | 103.7±24.2# | 70.7±13.0# |
Values are means ± standard error (SEM) for 3 independent experiments per each treatment. Values are statistically significant at
*
p<0.05 Vs. control;
#
p<0.05 Vs. diabetic group #p<0.05 Vs. diabetic metformin group. GPT; glutamate pyruvate transaminase; GOT; Glutamic-oxaloacetate transaminases.